Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3239623rdf:typepubmed:Citationlld:pubmed
pubmed-article:3239623lifeskim:mentionsumls-concept:C0175677lld:lifeskim
pubmed-article:3239623lifeskim:mentionsumls-concept:C0035648lld:lifeskim
pubmed-article:3239623lifeskim:mentionsumls-concept:C0009780lld:lifeskim
pubmed-article:3239623lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:3239623lifeskim:mentionsumls-concept:C0020388lld:lifeskim
pubmed-article:3239623lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:3239623lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:3239623pubmed:issue6lld:pubmed
pubmed-article:3239623pubmed:dateCreated1989-5-3lld:pubmed
pubmed-article:3239623pubmed:abstractTextBasal plasma hydroxyproline was measured in 104 male Navy Seal candidates 1 week into their intense physical training program, which lasted 7 weeks, and correlated to the incidence of connective tissue injuries incurred later in the training program. Eleven subjects (10.6%) were diagnosed as having connective tissue injuries. Those subjects with connective tissue injuries had a significantly higher (P less than 0.05) mean plasma hydroxyproline value (4.02 micrograms/ml) than subjects without injury (3.10 micrograms/ml). The majority of graduates (75%) had plasma hydroxyproline values less than 3.3 micrograms/ml. These graduates represented the strongest and most enduring injury-free subjects. Of the subject pool who incurred connective tissue injuries, only 27% had plasma hydroxyproline values less than 3.3 micrograms/ml. The majority of the injured subjects (73%) had plasma hydroxyproline values greater than or equal to 3.3 micrograms/ml. In conclusion, there is a relationship between initial training basal plasma hydroxyproline levels and connective tissue injuries later incurred in an intense physical training program. These data suggest that elevated plasma hydroxyproline levels may represent a risk factor associated with connective tissue injuries.lld:pubmed
pubmed-article:3239623pubmed:languageenglld:pubmed
pubmed-article:3239623pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3239623pubmed:citationSubsetIMlld:pubmed
pubmed-article:3239623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3239623pubmed:statusMEDLINElld:pubmed
pubmed-article:3239623pubmed:issn0363-5465lld:pubmed
pubmed-article:3239623pubmed:authorpubmed-author:RiedyMMlld:pubmed
pubmed-article:3239623pubmed:authorpubmed-author:NortonJJlld:pubmed
pubmed-article:3239623pubmed:authorpubmed-author:MandelbaumBBlld:pubmed
pubmed-article:3239623pubmed:authorpubmed-author:HodgdonJJlld:pubmed
pubmed-article:3239623pubmed:authorpubmed-author:MurguiaM JMJlld:pubmed
pubmed-article:3239623pubmed:authorpubmed-author:VailasAAlld:pubmed
pubmed-article:3239623pubmed:authorpubmed-author:GoforthHHlld:pubmed
pubmed-article:3239623pubmed:issnTypePrintlld:pubmed
pubmed-article:3239623pubmed:volume16lld:pubmed
pubmed-article:3239623pubmed:ownerNLMlld:pubmed
pubmed-article:3239623pubmed:authorsCompleteYlld:pubmed
pubmed-article:3239623pubmed:pagination660-4lld:pubmed
pubmed-article:3239623pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3239623pubmed:meshHeadingpubmed-meshheading:3239623-...lld:pubmed
pubmed-article:3239623pubmed:meshHeadingpubmed-meshheading:3239623-...lld:pubmed
pubmed-article:3239623pubmed:meshHeadingpubmed-meshheading:3239623-...lld:pubmed
pubmed-article:3239623pubmed:meshHeadingpubmed-meshheading:3239623-...lld:pubmed
pubmed-article:3239623pubmed:meshHeadingpubmed-meshheading:3239623-...lld:pubmed
pubmed-article:3239623pubmed:meshHeadingpubmed-meshheading:3239623-...lld:pubmed
pubmed-article:3239623pubmed:meshHeadingpubmed-meshheading:3239623-...lld:pubmed
pubmed-article:3239623pubmed:meshHeadingpubmed-meshheading:3239623-...lld:pubmed
pubmed-article:3239623pubmed:meshHeadingpubmed-meshheading:3239623-...lld:pubmed
pubmed-article:3239623pubmed:meshHeadingpubmed-meshheading:3239623-...lld:pubmed
pubmed-article:3239623pubmed:articleTitleElevated plasma hydroxyproline. A possible risk factor associated with connective tissue injuries during overuse.lld:pubmed
pubmed-article:3239623pubmed:affiliationDepartment of Kinesiology, University of California, Los Angeles.lld:pubmed
pubmed-article:3239623pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3239623pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3239623lld:pubmed